Piper Sandler & Co’s Allergan plc AGN.PRA Stock Holding History

Piper Sandler & Co’s Portfolio AGN.PRA Stock Details AGN.PRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-38,263	Closed	-$22.4M	–	22
2017 Q4	$22.4M	Buy	+38,263	New	+$24.7M	19.46%	3

Other funds holding AGN.PRA

PWS

Peloton Wealth Strategists Indianapolis, Indiana $271M AUM 19.14% 1-Year Est. Return

Piper Sandler & Co's AGN.PRA Position: Q1 2018 in Review

Piper Sandler & Co sold out of Allergan plc (AGN.PRA) in Q1 2018, closing a stake of 38,263 shares — an estimated $22.4M sold.

Piper Sandler & Co first reported a position in AGN.PRA in Q4 2017 and held it in 1 quarter. The position peaked at $22.4M in Q4 2017. 1 fund tracked by Wall St. Rank holds AGN.PRA as of Q1 2018.

Piper Sandler & Co reported no remaining Allergan plc position as of Q1 2018 after selling out during the quarter.
Piper Sandler & Co sold 38,263 Allergan plc shares in Q1 2018, an estimated $22.4M.
Piper Sandler & Co first reported a position in Allergan plc in Q4 2017 and held it in 1 quarter.
Piper Sandler & Co's Allergan plc position peaked at $22.4M in Q4 2017.
1 fund tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Piper Sandler & Co's 13F filing for Q1 2018, filed 15 May 2018.